Thalidomide: mechanisms of action.

Thalidomide: mechanisms of action.

Item
http://www.wikidata.org/entity/Q37147933
Growth factor and signaling pathways and their relevance to prostate cancer therapeuticsAngiogenesis inhibitors in the treatment of prostate cancer.Thalidomide prevents the progression of peritoneal fibrosis in mice.Angiogenesis inhibitors in the treatment of non-small cell lung cancerCentral neurotoxicity of immunomodulatory drugs in multiple myeloma.A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects.Drug repositioning for personalized medicine.Lenalidomide alone or lenalidomide plus dexamethasone significantly inhibit IgG and IgM in vitro... A possible explanation for their mechanism of action in treating multiple myelomaThalidomide effect in endothelial cell of acute radiation proctitis.Targeting angiogenesis for the treatment of prostate cancer.Lenalidomide in lymphomas and chronic lymphocytic leukemia.The efficacy and safety of thalidomide-based therapy in patients with advanced non-small cell lung cancer: a meta-analysis.
P2860

Thalidomide: mechanisms of action.

Item
http://www.wikidata.org/entity/Q37147933
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thalidomide: mechanisms of action.
@en
Thalidomide: mechanisms of action.
@nl
type
label
Thalidomide: mechanisms of action.
@en
Thalidomide: mechanisms of action.
@nl
prefLabel
Thalidomide: mechanisms of action.
@en
Thalidomide: mechanisms of action.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Thalidomide: mechanisms of action.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921